Trial reportAmerican journal of nephrology2010
Impact of reduced kidney function on cardiopulmonary fitness in patients with systolic heart failure.
Trial report in American journal of nephrology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 25 citations in OpenAlex.
- Cardiorenal syndrome and the association with fitness: Data from a telerehabilitation randomized clinical trial.ESC heart failure · 2022Trial
- Anemia and associated clinical outcomes in patients with heart failure due to reduced left ventricular systolic function.Clinical cardiology · 2013Trial
- Admission Renal Dysfunction Severity as a Prognostic Factor in Older Patients With Acute Heart Failure.Circulation reports · 2026Article
- CA125 outperforms NT-proBNP in the prediction of maximum aerobic capacity in heart failure with preserved ejection fraction and kidney dysfunction.Clinical kidney journal · 2024Article
- Determinants of Peak Oxygen Uptake at Each Stage of Renal Dysfunction in Patients with Heart Disease.Reviews in cardiovascular medicine · 2022Article
- The predictive value of coronary artery calcification score combined with bone mineral density for the 2-year risk of cardiovascular events in maintenance hemodialysis patients.International urology and nephrology · 2022Article
- Estimated Glomerular Filtration Rate Variability in Patients With Heart Failure and Chronic Kidney Disease.Journal of cardiac failure · 2021Article
- Role of comorbidities in heart failure prognosis Part 2: Chronic kidney disease, elevated serum uric acid.European journal of preventive cardiology · 2020Review
- Physical activity, cognitive function, and brain health: what is the role of exercise training in the prevention of dementia?Brain sciences · 2012Article
- Cardiovascular disease in chronic kidney disease: data from the Kidney Early Evaluation Program (KEEP).Current diabetes reports · 2011Review
- Article
- 6-minute walking test: a useful tool in the management of heart failure patients.Therapeutic advances in cardiovascular diseaseReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDecreased renal function has been consistently associated with increased mortality among patients with systolic heart failure. The relationship between estimated glomerular filtration rate (eGFR) and other high-risk features including reduced cardiorespiratory fitness has not been previously reported in this patient population.
methodsThe HF-ACTION trial was a prospective, randomized trial of exercise therapy versus usual care in patients with systolic heart failure. Patients with class 2-4 heart failure and a left ventricular ejection fraction of ≤ 35% were recruited. Serum creatinine was measured up to 1 year prior to entry. The 4-variable modified Modification of Diet in Renal Disease equation was used to calculate eGFR. Peak oxygen consumption (peak VO(2)) was directly measured using gas exchange analysis during progressive exercise testing to volitional fatigue or adverse signs/symptoms.
resultsOf 2,091 subjects (mean age 59 ± 13 years, with serum creatinine available at baseline), 72% were men, and 61, 33, and 5% were Caucasians, African Americans, and others, respectively. Older age, diabetes, and hypertension were all more frequent with declining eGFR. The Pearson correlation between eGFR and peak VO(2) was 0.22 (p < 0.0001). Age was negatively correlated with both eGFR (r = -0.44, p < 0.0001) and peak VO(2) (r = -0.27, p < 0.0001). The peak VO(2) tended to decline across decreasing levels of eGFR. Individuals with an eGFR <30 ml/min/1.73 m(2) had, on average, 2.1 high-risk features including peak VO(2) <14 ml/kg/min, age >75 years, diabetes, and functional class 3-4 symptoms. Conversely, those with an eGFR >90 ml/min/1.73 m(2) had relatively few (1.0) high-risk characteristics.
conclusionsReduced renal filtration is associated with impaired cardiorespiratory fitness and a clustering of high-risk features in systolic heart failure patients which portend a more complicated course and higher all-cause mortality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.